Mucinex
NDC 17856-0008, Guaifenesin, tablet, extended release, from ATLANTIC BIOLOGICAS CORP..
- Product NDC
- 17856-0008
- Status
- Listed
- Labeler
- ATLANTIC BIOLOGICAS CORP.
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- NDA
- Application
- NDA021282
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/17856-0008 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GUAIFENESIN600 mg/1
Pharmacologic classes
Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 17856-0008-2 | 17856000802 | 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (17856-0008-2) |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 17856-0008 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/17856-0008 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 17856-0008. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.